Bionime Corporation (4737.TW)
TWD 66.0
(-0.9%)
TWD 66.0
(-0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 203.44 Million | 142.29 Million | 269.72 Million | 217.55 Million | 405.55 Million | 121.89 Million |
| Net Income | -31.87 Million | 86.48 Million | 74.58 Million | 31.11 Million | 134.56 Million | 161.96 Million |
| Depreciation & Amortization | 163.42 Million | 153.23 Million | 154.65 Million | 163.48 Million | 164.48 Million | 151.33 Million |
| Deferred income taxes | -81.54 Million | - | -28.3 Million | -9.33 Million | -25.87 Million | -28.86 Million |
| Stock-based compensation | 4.78 Million | 7.85 Million | 12.77 Million | 15.53 Million | 13.69 Million | 20.63 Million |
| Change in working capital | 104.74 Million | -138.49 Million | 37.66 Million | -3.27 Million | 85.2 Million | -210.51 Million |
| Other non-cash items | 43.91 Million | 33.22 Million | 18.34 Million | 20.03 Million | 33.47 Million | 27.35 Million |
| Investing Cash Flow | -435.26 Million | -312.25 Million | -288.07 Million | -330.76 Million | -129.09 Million | 110.4 Million |
| Investments in PPE | -441.39 Million | -312.92 Million | -284.56 Million | -296.39 Million | -138.07 Million | -168.76 Million |
| Acquisitions | -1.01 Million | 4.73 Million | - | 33.62 Million | -49.57 Million | 7.98 Million |
| Investment purchases | 5.99 Million | -3.56 Million | -3.77 Million | -33.62 Million | -6 Million | -6.71 Million |
| Sales/Maturities of investments | 5.99 Million | -4.73 Million | - | -33.62 Million | 16.15 Million | 273.69 Million |
| Other Investing Activities | -4.84 Million | 4.22 Million | 274 Thousand | -752 Thousand | 48.4 Million | 5.47 Million |
| Financing Cash Flow | 420.4 Million | 113.63 Million | -69.29 Million | 96.33 Million | -338.02 Million | 20.54 Million |
| Debt repayment | -374.5 Million | -3.12 Billion | -39.9 Million | -2.5 Billion | -2.12 Billion | -2.04 Billion |
| Dividends payments | -127.68 Million | -121.2 Million | -124.28 Million | -118.66 Million | -114.89 Million | -237.83 Million |
| Common Stock Repurchased | - | - | - | 2.65 Billion | 1.85 Billion | - |
| Common Stock Issuance | 10.46 Million | 9.31 Million | 30.56 Million | 67.97 Million | 52.05 Million | - |
| Other Financing Activities | 173.58 Million | 3.35 Billion | 15.08 Million | 393 Thousand | 1.99 Million | 2.3 Billion |
| Accounts receivables | 208.74 Million | -350.94 Million | 96.31 Million | 274.32 Million | 76.27 Million | -223.03 Million |
| Accounts payables | -31.5 Million | 28.06 Million | 4.81 Million | -2.72 Million | -13.79 Million | 18.02 Million |
| Inventory | 47.17 Million | 49.77 Million | -71.55 Million | -125.18 Million | 16.06 Million | -49.95 Million |
| Other working capital | -119.66 Million | 134.61 Million | 8.09 Million | -149.68 Million | 6.65 Million | -160.56 Million |
| Cash at beginning of period | 214.48 Million | 253.08 Million | 343.24 Million | 359.55 Million | 433.63 Million | 174.34 Million |
| Cash at end of period | 391.82 Million | 214.48 Million | 253.08 Million | 343.24 Million | 359.55 Million | 433.63 Million |
| Capital Expenditure | -441.39 Million | -312.92 Million | -284.56 Million | -296.39 Million | -138.07 Million | -168.76 Million |
| Effect of forex changes on cash | -11.25 Million | 17.73 Million | -2.51 Million | 567 Thousand | -12.51 Million | 6.43 Million |
| Net cash flow / Change in cash | 177.33 Million | -38.59 Million | -90.16 Million | -16.31 Million | -74.07 Million | 259.28 Million |
| Free Cash Flow | -237.95 Million | -170.62 Million | -14.84 Million | -78.83 Million | 267.48 Million | -46.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.81 Million | -5.03 Million | -26.39 Million | -31.87 Million | -13.04 Million | 23.13 Million |
| Depreciation & Amortization | 42.36 Million | 41.84 Million | 41.17 Million | 163.42 Million | 42.06 Million | 41.17 Million |
| Deferred income taxes | - | - | -13.81 Million | -81.54 Million | -13.65 Million | -40.73 Million |
| Stock-based compensation | 4.27 Million | 661 Thousand | 1.19 Million | 4.78 Million | 1.19 Million | 1.19 Million |
| Change in working capital | -46.17 Million | 27.61 Million | 11.6 Million | 104.74 Million | 30.19 Million | -89.39 Million |
| Other non-cash items | 220 Million | 45.39 Million | 12.19 Million | 43.91 Million | 12.24 Million | 10.31 Million |
| Investing Cash Flow | -79.55 Million | -87.88 Million | -107.35 Million | -435.26 Million | -132.75 Million | -65.01 Million |
| Investments in PPE | -79.03 Million | -83.59 Million | -109.21 Million | -441.39 Million | -137.65 Million | -69.3 Million |
| Acquisitions | - | - | -1.6 Million | -1.01 Million | -211 Thousand | - |
| Investment purchases | -457 Thousand | -4.24 Million | 1.6 Million | 5.99 Million | 5.33 Million | 3.36 Million |
| Sales/Maturities of investments | - | - | 1.6 Million | 5.99 Million | 4.39 Million | - |
| Other Investing Activities | -62 Thousand | -44 Thousand | 259 Thousand | -4.84 Million | -4.61 Million | 924 Thousand |
| Financing Cash Flow | 48.85 Million | -55.83 Million | 180.73 Million | 420.4 Million | 105.9 Million | 122.32 Million |
| Debt repayment | -51.06 Million | -56.97 Million | -74 Thousand | -374.5 Million | -384.39 Million | -94.94 Million |
| Dividends payments | - | - | - | -127.68 Million | -127.68 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 300 Thousand | 3.57 Million | 6.55 Million | 10.46 Million | 972 Thousand | 661 Thousand |
| Other Financing Activities | 41 Thousand | 90 Thousand | 180.81 Million | 173.58 Million | -150.79 Million | 27.37 Million |
| Accounts receivables | -142.51 Million | 33.12 Million | -60.88 Million | 208.74 Million | 11.87 Million | -20.74 Million |
| Accounts payables | 7.48 Million | -4.9 Million | 23 Million | -31.5 Million | -8.38 Million | -42.29 Million |
| Inventory | -7.85 Million | 9.68 Million | 36.78 Million | 47.17 Million | 43.85 Million | 17.69 Million |
| Other working capital | 96.7 Million | -10.28 Million | 12.69 Million | -119.66 Million | -17.15 Million | -44.04 Million |
| Cash at beginning of period | 334.97 Million | 391.82 Million | 314.93 Million | 214.48 Million | 272.94 Million | 268.7 Million |
| Cash at end of period | 259.53 Million | 334.97 Million | 391.82 Million | 391.82 Million | 314.93 Million | 272.94 Million |
| Capital Expenditure | -79.03 Million | -83.59 Million | -109.21 Million | -441.39 Million | -137.65 Million | -69.3 Million |
| Effect of forex changes on cash | 2.47 Million | 22.84 Million | -22.45 Million | -11.25 Million | 9.84 Million | 1.25 Million |
| Net cash flow / Change in cash | -75.44 Million | -56.84 Million | 76.88 Million | 177.33 Million | 41.99 Million | 4.23 Million |
| Free Cash Flow | -126.26 Million | -19.56 Million | -83.25 Million | -237.95 Million | -78.66 Million | -123.62 Million |
1752
VIVC
2120
603279
6028
PD